Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | |
| Cash Flows From Operating Activities | |
| Net Income | -12,475 |
| Depreciation Amortization | 1,942 |
| Accounts receivable | -1,718 |
| Accounts payable and accrued liabilities | -401 |
| Other Working Capital | 832 |
| Other Operating Activity | 2,205 |
| Operating Cash Flow | $-9,615 |
| Cash Flows From Investing Activities | |
| Change In Deposits | 9,269 |
| PPE Investments | -4,100 |
| Investing Cash Flow | $5,169 |
| Cash Flows From Financing Activities | |
| Debt Issued | 4,168 |
| Debt Repayment | -741 |
| Common Stock Issued | 23 |
| Financing Cash Flow | $3,450 |
| Beginning Cash Position | 3,022 |
| End Cash Position | 2,026 |
| Net Cash Flow | $-996 |
| Free Cash Flow | |
| Operating Cash Flow | -9,615 |
| Capital Expenditure | -4,100 |
| Free Cash Flow | -13,715 |